Identification of transcriptional targets associated with the expression of p210 Bcr-Abl.
about
Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity.Canonical and new generation anticancer drugs also target energy metabolism.Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycinSystems-wide analysis of a phosphatase knock-down by quantitative proteomics and phosphoproteomics.Quantitative- and phospho-proteomic analysis of the yeast response to the tyrosine kinase inhibitor imatinib to pharmacoproteomics-guided drug line extension.
P2860
Identification of transcriptional targets associated with the expression of p210 Bcr-Abl.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Identification of transcriptional targets associated with the expression of p210 Bcr-Abl.
@en
type
label
Identification of transcriptional targets associated with the expression of p210 Bcr-Abl.
@en
prefLabel
Identification of transcriptional targets associated with the expression of p210 Bcr-Abl.
@en
P2860
P1476
Identification of transcriptional targets associated with the expression of p210 Bcr-Abl.
@en
P2093
Fionnuala B Hickey
Thomas G Cotter
P2860
P304
P356
10.1111/J.1600-0609.2006.00629.X
P577
2006-02-23T00:00:00Z